TheraVitae Announce the Appointment of new Vice-President
Friday, June 09, 2006 - Stem Cell Guru
Daniel A. Szobel Appointed Vice-President of Global Operations for Stem Cell Company - TheraVitae Group
Dr. Valentin Fulga, CEO of TheraVitae Group, recently announced the appointment of Daniel A. Szobel, as Vice-President of Global Operations. Mr. Szobel takes immediate charge of TheraVitae’s operations worldwide and will be based in Israel.
Dr. Valentin Fulga, CEO of TheraVitae Group, recently announced the appointment of Daniel A. Szobel, as Vice-President of Global Operations. Mr. Szobel takes immediate charge of TheraVitae’s operations worldwide and will be based in Israel.
TheraVitae is a multinational company focused on developing and using stem cells from the patient's own blood to treat a variety of disorders.
Confirming the appointment, on behalf of TheraVitae’s board of directors, Dr. Valentin Fulga, CEO of TheraVitae Group, welcomed Mr. Szobel, “We are delighted that Daniel has chosen to further his already distinguished career with us at Theravitae. He brings with him proven leadership experience with both biotech and multinational pharmaceutical companies and is ideally suited to guiding TheraVitae towards accomplishing our future goals.” said Dr. Fulga.
Szobel, 38, joins TheraVitae from his previous position as Finance and Operations Manager at Schering-Plough, Israel; a position in which he was responsible for all of the logistical and operational aspects of company's activities in Israel. Previously Mr. Szobel gained valuable experience as V.P. of Finance and Administration at leading biotech firm Proneuron Biotechnologies Inc. Szobel graduated with a BA in Accounting and Economics from Tel Aviv University and is a Certified Public Accountant (CPA).
Szobel said that he was looking forward to joining the TheraVitae team and was confident of playing a significant role in leading the company forward saying, “I am excited to join Theravitae's intrepid and experienced management team on the journey to becoming a world leader in the field of Cell Therapy.”
View the full Press Release.
Download Press Release in PDF format.
Dr. Valentin Fulga, CEO of TheraVitae Group, recently announced the appointment of Daniel A. Szobel, as Vice-President of Global Operations. Mr. Szobel takes immediate charge of TheraVitae’s operations worldwide and will be based in Israel.
Dr. Valentin Fulga, CEO of TheraVitae Group, recently announced the appointment of Daniel A. Szobel, as Vice-President of Global Operations. Mr. Szobel takes immediate charge of TheraVitae’s operations worldwide and will be based in Israel.
TheraVitae is a multinational company focused on developing and using stem cells from the patient's own blood to treat a variety of disorders.
Confirming the appointment, on behalf of TheraVitae’s board of directors, Dr. Valentin Fulga, CEO of TheraVitae Group, welcomed Mr. Szobel, “We are delighted that Daniel has chosen to further his already distinguished career with us at Theravitae. He brings with him proven leadership experience with both biotech and multinational pharmaceutical companies and is ideally suited to guiding TheraVitae towards accomplishing our future goals.” said Dr. Fulga.
Szobel, 38, joins TheraVitae from his previous position as Finance and Operations Manager at Schering-Plough, Israel; a position in which he was responsible for all of the logistical and operational aspects of company's activities in Israel. Previously Mr. Szobel gained valuable experience as V.P. of Finance and Administration at leading biotech firm Proneuron Biotechnologies Inc. Szobel graduated with a BA in Accounting and Economics from Tel Aviv University and is a Certified Public Accountant (CPA).
Szobel said that he was looking forward to joining the TheraVitae team and was confident of playing a significant role in leading the company forward saying, “I am excited to join Theravitae's intrepid and experienced management team on the journey to becoming a world leader in the field of Cell Therapy.”
View the full Press Release.
Download Press Release in PDF format.
Site Feed
0 Comments:
Post a Comment
<< Home